- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03058055
Brain Exercises for Synaptic Plasticity (BEST)
December 17, 2017 updated by: Gregory Jicha, 323-5550, University of Kentucky
Brain Exercises for Synaptic Plasticity: the BEST Study
The BEST study will investigate the feasibility of cognitive interventions in a randomized, placebo-controlled, clinical trial.
The investigators will recruit 45 cognitively normal subjects and engage them in one of three cohorts over an 8 week period, including active reading vs. origami study arms and a placebo group without structured cognitive intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a randomized, placebo controlled study investigating the practical implementation and conduct of two cognitive interventions in non-demented subjects.
Subjects will be randomized 1:1:1 into three groups including: 1) a Book club that includes weekly one hour meetings and daily reading assignments, 2) Origami lessons (one hour/week) with daily take home Origami activities to complete, and 3) a placebo group with unstructured lifestyle activities (normal lifestyle activities without restraint).
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536
- Sander's Brown Center on Aging
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Non demented community dwelling elders
Exclusion Criteria:
- Unable to perform the reading or origami tasks for any reason
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
Usual lifestyle activities
|
The placebo group will have unstructured lifestyle activities (normal lifestyle activities without restraint).
|
|
Experimental: Origami
Origami lessons (one hour/week) with daily take home Origami activities to complete
|
Origami lessons (one hour/week) with daily take home Origami activities to complete
|
|
Experimental: Reading
Daily reading (out loud into a voice recorder) for one hour
|
Book club that includes weekly one hour meetings and daily reading assignments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MOCA
Time Frame: 8 weeks
|
The Montreal Cognitive Assessment (MOCA) measures general cognitive function
|
8 weeks
|
|
FCSRT
Time Frame: 8 weeks
|
The Free and Cued Selective Reminding Test (FCSRT) measures memory function.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to protocol
Time Frame: 8 weeks
|
Objective measures of weekly time devoted to cognitive training activities
|
8 weeks
|
|
Electroencephalogram
Time Frame: 8 weeks
|
resting state electroencephalogram pattern
|
8 weeks
|
|
Evoked Related Potential
Time Frame: 8 weeks
|
Evoked Related Potential P300 using the Bluegrass memory task
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gregory A Jicha, MD, PhD, University Of Kentucky
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 15, 2016
Primary Completion (Actual)
December 15, 2017
Study Completion (Actual)
December 15, 2017
Study Registration Dates
First Submitted
February 12, 2017
First Submitted That Met QC Criteria
February 17, 2017
First Posted (Actual)
February 20, 2017
Study Record Updates
Last Update Posted (Actual)
December 19, 2017
Last Update Submitted That Met QC Criteria
December 17, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- BEST
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Change
-
University Ramon LlullAinhoa Nieto Guisado; Mònica Solana-TramuntUnknownCognitive Change | Proprioception Change | Balance ChangeSpain
-
Applied Science & Performance InstituteCompletedCognitive Change | Mood Change | Mental ProcessesUnited States
-
National Council of Scientific and Technical Research...CompletedSleep | Cognitive Change | Mood Change | CreativityArgentina
-
Heilongjiang Feihe Dairy Co. Ltd.CompletedCognitive ChangeChina
-
University of MiamiMcKnight Brain Research FoundationCompleted
-
University of Wisconsin, MadisonNational Institute on Aging (NIA); University of California, Irvine; University...Completed
-
Tufts UniversityCompleted
-
Northeastern UniversityNational Institute on Aging (NIA); University of California, RiversideCompletedCognitive ChangeUnited States
-
Western University, CanadaInteraXon, Inc.; Cambridge Brain SciencesCompletedCognitive ChangeCanada
-
University of MiamiUnited States Department of DefenseTerminated
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of